History and exam

Key diagnostic factors

common

presence of risk factors

Key risk factors include non-metastatic malignancy (humoral hypercalcaemia), metastatic skeletal involvement (local osteolytic hypercalcaemia), and lymphoma (calcitriol [(1,25-dihydroxyvitamin D)]-mediated hypercalcaemia).

history of malignancy

Hypercalcaemia occurs in 20% to 30% of patients with cancer.[21][22] Cancer represents the most common aetiology of hypercalcaemia in the inpatient setting.[3] It can result from: humoral hypercalcaemia of malignancy (characterised by tumour secretion of parathyroid hormone-related peptide [PTHrP]); local osteolytic hypercalcaemia (characterised by local release of factors, including PTHrP, by bony metastases that promote osteoclast differentiation and function); calcitriol (1,25-dihydroxyvitamin D)-mediated hypercalcaemia (characterised by autonomous production of calcitriol [(1,25-dihydroxyvitamin D)] by lymphoma cells); and ectopic hyperparathyroidism (characterised by tumour production of parathyroid hormone), which is very rare.[21][5]

Other diagnostic factors

common

normal physical exam

Hypercalcaemia may not be associated with any specific physical examination findings.

poor skin turgor and/or dry mucous membranes

Signs of dehydration may be apparent on physical examination.

confusion

Hypercalcaemia may be associated with neuropsychiatric symptoms.

fatigue

Hypercalcaemia may be associated with neuropsychiatric symptoms.

constipation

Hypercalcaemia is associated with gastrointestinal symptoms.

loss of appetite

Hypercalcaemia is associated with gastrointestinal symptoms.

nausea

Hypercalcaemia is associated with gastrointestinal symptoms.

polyuria

Hypercalcaemia is associated with increased urinary excretion and dehydration by inducing nephrogenic diabetes insipidus.

polydipsia

Hypercalcaemia is associated with increased urinary excretion and dehydration.

bone pain

Hypercalcaemia is associated with bone pain.

Bone pain may be a feature of metastatic skeletal involvement.

use of hypercalcaemia-inducing medication

Medications that may cause or worsen hypercalcaemia include thiazide diuretics, lithium, calcium, over-the-counter antacids, and large doses of vitamin D.[21][5][23]

uncommon

stupor

Hypercalcaemia may be associated with neuropsychiatric symptoms. Stupor is a non-specific symptom that may result from hypercalcaemia, but has numerous toxic/metabolic and neurological aetiologies that need to be considered.

coma

Hypercalcaemia may be associated with neuropsychiatric symptoms. Coma is a non-specific symptom that may result from hypercalcaemia, but has numerous toxic/metabolic and neurological aetiologies that need to be considered.

Risk factors

strong

non-metastatic malignancy

Humoral hypercalcaemia of malignancy results from tumour secretion of parathyroid hormone-related peptide (PTHrP), and typically occurs with non-metastatic disease.[4]​ Types of cancer include renal cancer, ovarian cancer, breast cancer, endometrial cancer, and squamous cell carcinoma.[1][5][10]

metastatic skeletal involvement

Local osteolytic hypercalcaemia occurs with disease complicated by widespread skeletal involvement.[1] Types of cancer include breast cancer and multiple myeloma.[1][5][10][Figure caption and citation for the preceding image starts]: CT chest showing compression fracture of multiple vertebral bodies in a child presenting with acute lymphoblastic leukaemia. Biochemistry showed hypercalcaemia with a suppressed parathyroid hormone levelSukumar SP, Balachandran K, Sahoo JP, et al. Acute lymphocytic leukaemia presenting as a metabolic bone disease. BMJ Case Reports 2013; doi:10.1136/bcr-2013-008758 [Citation ends].com.bmj.content.model.Caption@38e7fc7d[Figure caption and citation for the preceding image starts]: Whole body planar images suggestive of skeletal infiltration in a child with acute lymphoblastic leukaemia showing areas of abnormal increased uptake. Biochemistry showed hypercalcaemia with a suppressed parathyroid hormone levelSukumar SP, Balachandran K, Sahoo JP, et al. Acute lymphocytic leukaemia presenting as a metabolic bone disease. BMJ Case Reports 2013; doi:10.1136/bcr-2013-008758 [Citation ends].com.bmj.content.model.Caption@6f0e48de

lymphoma

Calcitriol (1,25-dihydroxyvitamin D)-mediated hypercalcaemia occurs with lymphomas of all types, including human T-lymphotrophic virus-associated lymphoma.[1][10]

Use of this content is subject to our disclaimer